Thrombotic microangiopathy during pregnancy
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Microvascular Research
- Vol. 138, 104226
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2013
- Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical PhenotypeJournal of the American Society of Nephrology, 2013
- Complement Factor H–Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic SyndromeClinical Journal of the American Society of Nephrology, 2013
- Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndromeKidney International, 2011
- Circulating angiogenic and antiangiogenic factors in women with eclampsiaAmerican Journal of Obstetrics and Gynecology, 2011
- Bevacizumab Increases Risk for Severe Proteinuria in Cancer PatientsJournal of the American Society of Nephrology, 2010
- Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene MutationsJournal of the American Society of Nephrology, 2010
- Role of complement and complement regulators in the removal of apoptotic cellsMolecular Immunology, 2008
- Thrombotic Thrombocytopenic Purpura Masquerading as Hemolysis, Elevated Liver Enzymes, Low Platelets (HELLP) Syndrome in Late PregnancyObstetrics & Gynecology, 2006
- Preeclampsia: the Death of GoliathAmerican Journal of Reproductive Immunology, 2006